The Dayton Development Coalition is giving the business a $1.1 million entrepreneurial signature fund loan, and the company has raised nearly $4 million from its round of financing.
NovoSource plans to distinguish itself from competitors through providing lower-cost options for knee implants and hip devices. Founders look to help orthopedic practices save $500,000 to $1 million each year with NovoSource devices, according to the report.
More Articles on Devices:
25 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in January
Stanmore Receives FDA Approval for Robotic Partial Knee Surgery
Zimmer Must Pay Stryker $70M for Patent Infringement
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.